{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:12:35Z","timestamp":1792638755361,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["21788"],"award-info":[{"award-number":["21788"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["023273"],"award-info":[{"award-number":["023273"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jhep.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T23:19:09Z","timestamp":1528931949000},"page":"534-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Grand Rounds: Alcoholic Hepatitis"],"prefix":"10.1016","volume":"69","author":[{"given":"Ashwani K.","family":"Singal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2018.05.001_b0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-230X-13-55","article-title":"White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers","volume":"13","author":"Hardy","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2018.05.001_b0020","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2011.02.021","article-title":"The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis","volume":"55","author":"Mookerjee","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0025","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.05.001_b0030","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/acer.13108","article-title":"Diagnosis and treatment of alcoholic hepatitis: a systematic review","volume":"40","author":"Singal","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2018.05.001_b0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","article-title":"Transjugular liver biopsy\u2013indications, adequacy, quality of specimens, and complications\u2013a systematic review","volume":"47","author":"Kalambokis","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0040","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.05.001_b0045","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.29080","article-title":"A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis","volume":"66","author":"Bissonnette","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/acer.13546","article-title":"Carcinogenic etheno-DNA adducts in alcoholic liver disease: correlation with cytochrome P-4502E1 and fibrosis","volume":"42","author":"Mueller","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2018.05.001_b0060","first-page":"92A","article-title":"A promising biomarker in management of patients with alcoholic liver disease","volume":"66","author":"Singal","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20140101","article-title":"The Bioenergetic Health Index: a new concept in mitochondrial translational research","volume":"127","author":"Chacko","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhep.2018.05.001_b0070","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1053\/j.gastro.2016.02.073","article-title":"Changes in the intestinal microbiome and alcoholic and nonalcoholic liver diseases: causes or effects?","volume":"150","author":"Betrapally","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0080","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2018.05.001_b0085","first-page":"2205","article-title":"The differing effects of acute and chronic alcohol on gastric and intestinal permeability","volume":"89","author":"Keshavarzian","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.05.001_b0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0095","doi-asserted-by":"crossref","first-page":"180S","DOI":"10.1097\/01.alc.0000189276.34230.f5","article-title":"Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease","volume":"29","author":"McClain","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2018.05.001_b0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0105","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/liv.12939","article-title":"Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials","volume":"36","author":"Hmoud","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.05.001_b0115","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2016.02.018","article-title":"Restoration of bactericidal activity of neutrophils by myeloperoxidase release: a new perspective for preventing infection in alcoholic cirrhosis","volume":"64","author":"Louvet","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/gutjnl-2015-310378","article-title":"Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase","volume":"66","author":"Vergis","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.05.001_b0125","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.21737","article-title":"Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome","volume":"46","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0130","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2015.12.005","article-title":"Impaired intracellular signaling, myeloperoxidase release and bactericidal activity of neutrophils from patients with alcoholic cirrhosis","volume":"64","author":"Boussif","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0135","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2014.11.041","article-title":"Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis","volume":"148","author":"Markwick","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0140","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2017.06.013","article-title":"Sepsis in alcohol-related liver disease","volume":"67","author":"Gustot","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0145","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2017.02.030","article-title":"Infection in severe alcoholic hepatitis: yet another piece in the puzzle","volume":"152","author":"Singal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0155","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2011.12.030","article-title":"C-reactive protein predicts short-term mortality in patients with cirrhosis","volume":"56","author":"Cervoni","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0160","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0165","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.05.001_b0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1196\/annals.1321.009","article-title":"Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies","volume":"1024","author":"Franchimont","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jhep.2018.05.001_b0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4292\/wjgpt.v4.i2.16","article-title":"Management practices of hepatitis C virus infected alcoholic hepatitis patients: a survey of physicians","volume":"4","author":"Singal","year":"2013","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.05.001_b0185","first-page":"612A","article-title":"Evaluation and management of alcoholic hepatitis: a survey of current practices","author":"Ahn","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4254\/wjh.v3.i8.205","article-title":"Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: current status","volume":"3","author":"Singal","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","author":"Gustot","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0200","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0205","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival","volume":"66","author":"Altamirano","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","article-title":"Increased tumor necrosis factor production by monocytes in alcoholic hepatitis","volume":"9","author":"McClain","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0215","first-page":"282","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.05.001_b0220","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0225","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs. without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2018.05.001_b0230","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.05.001_b0235","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0240","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0245","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1478-3231.2011.02604.x","article-title":"Antioxidants as therapeutic agents for liver disease","volume":"31","author":"Singal","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.05.001_b0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0255","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1572-0241.2002.05826.x","article-title":"Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review","volume":"97","author":"Rambaldi","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.05.001_b0260","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0016-5085(82)80050-4","article-title":"Propylthiouracil treatment for alcoholic hepatitis: the case of the missing thirty","volume":"83","author":"Orrego","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0265","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Banares","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0270","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0275","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.05.001_b0280","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0285","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0290","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4254\/wjh.v3.i5.125","article-title":"General aspects of the treatment of alcoholic hepatitis","volume":"3","author":"Babineaux","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0295","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.05.001_b0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.05.001_b0305","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1365-2036.2007.03302.x","article-title":"Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features","volume":"25","author":"Mathurin","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.05.001_b0310","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4065\/mcp.2010.0281","article-title":"Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis","volume":"86","author":"Vaa","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2018.05.001_b0325","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0330","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.05.001_b0335","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.05.001_b0340","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/apt.12654","article-title":"Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort","volume":"39","author":"Papastergiou","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.05.001_b0345","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0350","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0355","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0360","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/alcalc\/agw032","article-title":"Alcohol use after liver transplantation is independent of liver disease etiology","volume":"51","author":"Russ","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jhep.2018.05.001_b0365","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1874473707666141015215602","article-title":"Current management of alcoholic liver disease","volume":"7","author":"Singal","year":"2014","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.jhep.2018.05.001_b0370","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/alcalc\/agl033","article-title":"Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria","volume":"41","author":"McCallum","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jhep.2018.05.001_b0375","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.05.001_b0380","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.25544","article-title":"Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database","volume":"55","author":"Singal","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.05.001_b0385","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/lt.24208","article-title":"Liver transplantation for alcoholic hepatitis: a survey of liver transplant centers","volume":"21","author":"Hasanin","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.05.001_b0390","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the united states-a single-center experience","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2018.05.001_b0395","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/appi.psy.41.2.191","article-title":"Patterns and predictors of risk for depressive and anxiety-related disorders during the first three years after heart transplantation","volume":"41","author":"Dew","year":"2000","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jhep.2018.05.001_b0400","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12072-016-9770-1","article-title":"Live donor liver transplantation for alcoholic hepatitis","volume":"11","author":"Singal","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2018.05.001_b0405","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02281929."},{"key":"10.1016\/j.jhep.2018.05.001_b0410","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01912404."},{"key":"10.1016\/j.jhep.2018.05.001_b0415","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01809132."},{"key":"10.1016\/j.jhep.2018.05.001_b0420","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.05.001_b0425","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.05.001_b0430","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0036-1571297","article-title":"Therapeutic strategies for the treatment of alcoholic hepatitis","volume":"36","author":"Singal","year":"2016","journal-title":"Semin Liver Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818320476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818320476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T17:15:48Z","timestamp":1661447748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818320476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0168827818320476"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.05.001","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Grand Rounds: Alcoholic Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}